Stay updated on Nivolumab in ER+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.

Latest updates to the Nivolumab in ER+ Breast Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page now displays revision v3.6.5, replacing the previous v3.6.4. This indicates an updated version of the page's revision history.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new build of the page. No study details or user-facing content were changed.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedNew resources and documents have been added to the trial page, including a PDF of the Study Protocol and Statistical Analysis Plan provided by Bristol-Myers Squibb, and sponsor sections for clinical trial recruitment and information. The page also includes a Publications section and expanded keywords, improving access to official materials and related literature.SummaryDifference100%

- Check47 days agoChange DetectedRevision: v3.6.2 is now shown on the page. Several sponsor- and document-related footer items were removed, which changes how study documents and sponsor context are accessed while leaving the core trial details unchanged.SummaryDifference16%

- Check61 days agoChange DetectedThe page adds a recruitment status note and new guidance sections to help users join or understand the study, and updates the revision tag to v3.6.0 while adjusting the Intervention/Treatment heading.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page now displays the latest revision label Revision: v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the page versioning rather than a substantive content change.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in ER+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.